Monday, 17 August 2015

Health Experts Call For Funds To Boost Ebola Vaccine Shots

Last year, approximately 27,000 people were infected by the Ebola virus in West Africa. Several sources reveal that over 11,000 of them succumbed to the outbreak in 2014. The entire medical fraternity believes that effective Ebola vaccines would have saved many lives. However, the fact that the entire world now depends upon latest drugs or vaccine for the virus too cannot be ignored. This outbreak has affected mostly poor nations like Liberia, Leone and more. It was only after a public alarm; health officials from regions like Europe as well as United States paid a visit to West Africa. The sudden outbreak also persuaded scientists to develop and test potential vaccine candidates that had been awaiting consent for years. Several clinical trials in regions including Guinea too show that the latest inventions have proved fruitful.

 In addition, close to $ 8 billion was spent in Guinea, Liberia and Sierra Leone for the development of Ebola drugs and treatment reported ‘NY Times ‘.  The same source revealed that getting a vaccine costs anywhere between $500 million as well as $1 billion. These funds help several drug manufacturers or biotechnology firms and scientists that are working hard to produce vaccines but are deprived of resources to manufacture them or seek an approval. Moreover, with the ‘World Health Organization’ supporting clinical trials of the vaccine in areas including Guinea has acted as a boon for fund raising and has attracted contributions from several private companies and drug makers for new virus vaccine.

In July 2015, health experts from across the global seconded the need for creating a $2 billion Ebola virus vaccine production fund to boost new shots. Commenting on this the Welcome Trust’s director, Jeremy Farrar said "We can no longer sit back and ignore the chronic lack of progress in developing new vaccines, and improving existing ones." Jeremy was of the co – writers responsible for creating the fund. Allied Market Research has added a report titled “Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020.” As per the report the vaccine manufacturing in regions such as Asia – Pacific, LAMEA, Europe and North America would observe tremendous growth.

Friday, 7 August 2015

Technology Trends Drives The Capsule Endoscopy System In 2015

Over the past few years medical sensors have become smaller. The MEMS (or Microelectrical-mechanical systems) have been popular in medical equipment, from stents to chemosensor. Even the capsule endoscopy systems comes with a miniature camera as well as radio technologies. These systems captures the images of human digestive tract from the inside. Latest discoveries in the data analytics, material science and equipment engineering collectively promise a much smaller and modish sensor. 

The recent development in miniaturization assures biocompatibility. Medical experts believe that the smaller the system, the less likely it would interfere with the immune mechanism. This is true for capsule endoscopy used to take images of the entire gastrointestinal tract. PillCam® SB launched by Covidien boasts of vitamin –sized, wireless pill design that can improve the diagnosis for small bowel diseases. Recently, a Vanderbilt University engineer, Pietro Valdastri received $1.5 million as grant to continue the development of his a unique magnetic capsule for patients with IBD.  

Besides this, miniaturization when combined with the latest electrochemical as well as optical techniques boosts specificity & sensitivity for several medical conditions or uses. For example, scientists indicate that when size of the capsule endoscopy system is reduced it allows medical professional pick up the elements on the device. The Qatar International Medical Congress held between May 26 – 28, 2015 also included video capsule endoscopy as well as many sensitive, yet important, next generation concepts on palliative care.

Apart from this, boom in data analytics have also observed some of the greatest advancements in the medical sensors industry. Medical experts now combine the sensor data with improved analytics as well as machine learning techniques to diagnose diseases accurately. Allied Market Research has published a report titled “World Capsule Endoscopy System - Market Opportunities and Forecast, 2014 – 2020.” As per the report the capsule endoscopy system would register a CAGR of 14.8 percent during the forecast period of 2014 to 2020 worldwide. The aforementioned report also uncovers there would a significant development of the capsule endoscopy system in regions such as North America, LAMEA, Asia Pacific and Europe.

Thursday, 6 August 2015

Specialty enzymes find immense application in therapeutics

Enzymes are proteins naturally produced by living organisms that stimulate and speed up bio-chemical reactions. These prove beneficial in building new cells, repairing damaged ones in the blood and tissues of organisms. As these are multifunctional and have high specificity, they find widespread applications in pharmaceutical industries, in diagnosing chronic diseases and in the treatment of various ailments including cancer, cardiovascular diseases and more. Several Industrial and household catalysis depends on the activity of enzymes as they lower activation energy and improve manufacturing efficiencies. Besides, they are cost effective and act as eco-friendly catalysts in various industrial, environmental and consumer products.

Specialty enzymes are proteins that are used in pharma, biotech & diagnostics, and act as biocatalysts in reaction, accelerating the pace of reactions thus acting as a cost-effective and eco-friendly entity in industrial and environmental products. Specialty enzymes find immense applications in areas such as molecular biology and creating molecules that have effective therapeutic uses. These enzymes are recommended by doctors to control incidences of digestive disorders, recent clinical trials point towards reliable evidences in being used as treatment therapy for diseases like cancer. Administered individually or with other treatments specialty enzymes such as prolactazyme, collagenase treats skin ulcer. Enzymes like asparaginase and streptokinase are used to treat various diseases. These enzymes are used in small amounts in therapeutics so that they do not cause any side effect. Furthermore, they must be highly purified and have a high degree of specificity. For instance alkaline phosphatase and peroxides are used in immunoassays.

Recently, researchers at the Centenary Institute in Sydney have uncovered new information about an enzyme called DPP9. They believe DPP9 is a potential therapeutic target and limits the growth of cancerous cells in liver. Currently, the molecule is highly powerful and needs to be externally regulated. Researches are also trying to ascertain how the cells of the body can achieve this naturally. Professor Mark Gorrell, who is behind the discovery of DPP9, is currently researching on the functionalities of the enzyme. There are other such endeavors undertaken by the research departments of prominent pharma industries and market analysts are observant of the growth dynamics of global specialty enzymes. Recently, a report by Allied Market Research titled “World Specialty Enzymes (Pharmaceuticals, Biotechnology R&D, Diagnostics)”. As per the report, specialty enzymes market for biotechnology research, pharmaceuticals and diagnostics was valued at $561.9 million in the year 2014 and would generate a revenue of $947.5 million by the end of 2020, growing at 9.4% CAGR amid the period 2015 - 2020.

Tuesday, 4 August 2015

Biosimilar Drugs Promises Cost Effective Treatment Even For Deadly Diseases

Follow- on biologics (FOBs) is a biological, inventor developed product that has greater similarity to biological products that has been already approved. Both approved biological medicines and FOBs have no clinical difference when it comes to the safety as well as potency of the products. The application of FOBs also popular as biosimilars in blood disorders, Oncology diseases, deficiencies in growth hormones plus may others, exhibit the greatest market potential as a result of dynamic patent scenario. 

Wider choice for biologic oncology treatment have now invaded markets including United States. The arrival of biologic for cancer treatment would help drive low cost for many of the highly –priced products in patient care. Treatments that worked as restraint for cancer’s biological substructure have undergone drastic change for some cancer types. The arrival of biosimilar now accounts for approximately ½ cancer medicine spending up from nearly 11 percent 10 years back reported IMS Institute. Recently, Hetero pharmaceuticals introduced their biosimilar medicine Rituximab in India under MABALL found effective in treating blood cancer.

In another incident the FDA recognised the first FOBs in the US. The regulatory body confirmed that the medicine Zarxio can now be used for various chemotherapy treatments. This drug aids in the production of white bloods cells in a patient’s body. Besides this, the drug is a generic make of the Neupogen. Apart from this absence of cost effective drug in the GHD treatment market also signifies great opportunity, because the latest biologics popular as biobetters is costly.

Today, FOBs are being used to a greater extent in NHS. Similarly, NICE also comprises of biosimilars in its new technology which is an appraisal on somatropin. Health professionals believe that the biosimilar drugs for hormonal deficiency would be highly accessible and become popular over the next four to five years Biosimilars provide NHS significant cost saving, majorly as they are effective for treating long – term medical conditions.

AlliedMarket Research has published a report titled “World Biosimilars/Follow-on-Biologics - Market Opportunities and Forecast, 2014 – 2020.” As per the report the FOBs industry would register a growth of nearly 49.1 percent during the forecast period 2014 to 2020.

Monday, 3 August 2015

Radial tires has revolutionized the global pneumatic tires industry

The market of tires in general is driven by the large scale manufacture of tires in automotive industry and their large adoption across passenger and industrial vehicles. Tires are highly engineered structural composites which are designed to provide good vehicle control and maneuvering, retreading and traction criteria, along with meeting safety and performance expectations of the customer.

Pneumatic tires are rubber tires filled with compressed air, the other raw materials being carbon black, steel wire, fabric, steel, polyester, nylon, and rayon, fabric cord and wires. The pneumatic tire market is largely driven by a tremendous increase in automobile production globally along with rise in the demand of tires in the replacement market.

The global pneumatic tire market is segmented based on the vehicle type, type of sale, product type and geographical locations. On the basis of type, pneumatic tires market is segmented into radial and cross-ply tires. On the basis of the type of vehicle, the global pneumatic tires market is segmented into two-wheelers, four-wheelers, aircraft, industrial vehicles, agricultural vehicles amongst others. Based on the above type, four wheelers tire segment generates the maximum revenue-generating category. Among four wheelers, pneumatic tires market is gaining prominence in being used in passenger cars, industrial vehicles and their increased adoption in transportation industry.

The advent of radial tires has revolutionized the entire market of pneumatic tires offering high growth momentum to the global pneumatic tires market. The aforementioned segment amount for 68.8% of the total tire market in terms of value in the year 2014, growing at 7.2% CAGR amid the forecast period. Sometimes radials pneumatic tires are constructed with many layers of steel belts in the tread and sidewall which easily repel sharp-cutting objects such as nails and staples. A major German automotive manufacturing company, Continental AG, has recently launched pneumatic radial tire ContiRT20 useful particularly for their larger forklifts. They offer greater resistance to puncture, have increased lateral stability and high retreading potential.

Recently, Allied market Research has published a report titled “World Pneumatic Tire - Market Opportunities and Forecasts, 2014 - 2020”. As mentioned in the report, the global pneumatic tire market is expected to contribute a revenue of $287.5 billion by the end of 2020, growing at a CAGR of 7.0% amid the period of 2015–2020.  Key companies profiled in the report are Continental AG, Michelin, Cooper Tire & Rubber Company, The Goodyear Tire and Rubber, Bridgestone Corporation, Company, Hankook Tire Co. Ltd., Sumitomo Rubber, The Yokohama Rubber Co. Ltd., Industries Ltd., and Kumho Tire USA, Inc, amongst others.

Microwave Oven Maker Focus On Design Flexibility

Worldwide, people are taking to microwave cooking, as they believe it is healthy. To woo customers, microwave brands are now offering customers more than just, traditional cooking, grilling and steaming. Furthermore, with the aim to make these appliances a powerhouse of cooking, manufacturers are considering improvements in their existing freestanding or in –built features. Quick Touch model from Breville is a finest example that offers consumers a user-friendly interface. The brand enables users to adjust power level easily and accordingly to suit a particular food type. Breville’s top –selling make secures approximately 8.7% market value share in, the over $300 price category.

Another microwave manufacturer Panasonic is busy concentrating on the convenience of use, automatic features as well as whip smart technology to help buyers reap optimum benefits from their microwaves.  The new microwave innovation from the company promises multiple cooking techniques such as latest steaming feature for nutritious, delicious food, defrost function and more. Healthy and easy to cook meals also go hand – in – hand for microwaves from Sharp. Besides convenience cooking, the appliance enable easy meal preparation for nutrition – packed food at an affordable price and the trend is significantly visible in the Australia. The latest model from Sharp come with cutting - edge features including Sensor and Flatbed features, which makes the cooking experience easy and simple.

LG Electronics too has paid attention to innovation. The brand intends to introduce easy to clean microwave ovens.  Latest model ‘32-Litre Stainless Steel Convection Oven With Grill’ from the makers come with interior made of stainless steel backed by grease removal coating. The features make cleaning completely fuss-free. The model also boasts of its humidity sensor that instantly identifies vapour and can adjust the power levels as well as meal preparation time during cooking. Allied Market Research has published a report titled “World Microwave Oven Market - Opportunities and Forecasts, 2014 – 2020.” As per the report the microwave oven industry would observe growth in regions such as LAMEA, North America, Europe and Asia –Pacific.

Wednesday, 29 July 2015

Comfort Is The New Mantra Of Footwear Industry

Footwear’s are inspired by lifestyle! From flamboyantly decorated flip –flops, fabulous high heels to ballet flats footwear, brands are now assuring comfortable fun. Today, local and international manufacturers focus more on insole design, smart leather and custom – manufactured shoe-in-shoe features, dependable and flexible for walking on different surface.

Also, understanding that customers are looking for footwear that offers only pleasure, and no pain brand like ‘Naturalizer’ decided to enter women fashion duty shoe segment to fulfil safety requirements at work. Launched under the name ‘‘Naturalizer@work’, the brand uses patented multi-density foam inserts to ensure more breathability, resilient cushioning, moisture management and more. To carry company’s comfort legacy forward, Naturalizer has paired up with the components company Ortholite. The product would hit the company stores on August 15, 2015 and priced from $99 to $199.

Another, global player in the footwear Converse has finally decided to make the Chunks more comfortable. The new addition is an improved version of the brands ‘Chuck Taylor’ collection – and the key mantra would be comfort. Chuck II would cost buyers approximately $15 more than the existing collection, revealed Bloomberg. For all those who work on their feet all day long RefrigiWear had designed new shoe series including Iron Hiker, Rally Hiker and Rustic Hiker. The series feature cutting –edge VitaComfort™ layer with a 360 degree cushioning along with additional foam padding to ensure great comfort level. The innovative VitaComfort™ layer works as a shock absorber that help users’ lower back pain, foot as well as knee pain.

Other brands making feet happier than ever includes Dr. Scholl’s, Birkenstock, Crocs, Ugg Australia and Keds among many others. Allied Market Research has published a report titled “World Footwear - Market Opportunities and Forecasts, 2014 – 2020.” As per the report the footwear market in LAMEA, North America, Europe and Asia –Pacific would witness a significant growth.